CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activa...
Braun et al. find that CD155 on tumor cells drives the proteasomal degradation of the activating receptor CD226 on tumor-infiltrating CD8 T cells, thus promoting immune evasion and resistance to...
cell.com